Boston, MA 04\/09\/2014 (wallstreetpr) –\u00a0Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)<\/b> has been in a downtrend over the last few trading sessions, and we believe this trend to continue and traders are advised to remain short for the time to come.<\/p>\n
The stock can also be sold at current levels with a strict stop loss at $23.85 for targets of $19.75 and $17.90.<\/p>\n
Positional traders can hold shorts or initiate shorts at the current levels by maintaining a strict stop loss at $23 on a weekly closing basis for targets of $17.50 – $16.80 in the very medium term as the momentum indicators warrant a sell on the stock.<\/p>\n
Varonis Systems Inc. (NASDAQ:VRNS)<\/b><\/p>\n
<\/b>Varonis Systems Inc. (NASDAQ:VRNS)<\/b> saw a massive down move on Tuesday on the back of heavy volumes which suggests that the downtrend for the stock might continue and we might witness lower levels.<\/p>\n
Short term traders can look at shorting the stock from current levels for targets of $25.50 – $24.30 in the very short term as the momentum indicators do not seem to be witnessing any kind of a pull back. Traders can place their stop losses at $31.64.<\/p>\n
Positional traders can use this opportunity to book profits in the stock or move their stop losses to the current price to lock in gains<\/p>\n
MacroGenics Inc. (NASDAQ:MGNX)<\/b><\/p>\n
<\/b>MacroGenics Inc. (NASDAQ:MGNX)<\/b> currently is trading below its 50 day moving average that is at $34.17 level. We believe the stock can head lower towards the $22 levels and the first long term support for the counter comes at around $21.50<\/p>\n
Traders taking a short position should keep $21.50 as their target and can reverse their positions if the stock tries bouncing from that level. But if the particular mentioned level is broken one can continue holding the shorts for levels as low as $18<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 04\/09\/2014 (wallstreetpr) –\u00a0Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) has been in a downtrend over the last few trading sessions, and we believe this trend to […]<\/p>\n","protected":false},"author":2,"featured_media":19111,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264,263],"tags":[5970,5968,5971,5969,5511,5510],"stock_ticker":[],"class_list":["post-19103","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","category-technology","tag-dicerna-pharmaceuticals-inc-nasdaqdrna","tag-macrogenics-inc-nasdaqmgnx","tag-nasdaqdrna","tag-nasdaqmgnx","tag-nasdaqvrns","tag-varonis-systems-inc-nasdaqvrns","entry"],"acf":[],"yoast_head":"\n